XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial

Song, Yuanlin; Yao, Chen; Yao, Yongming; Han, Hui; Zhao, Xiaodong; Yu, Kaijiang; Liu, Luyi; Xu, Ying; Liu, Zhongmin; Zhou, Qingshan; Wang, Ying; Ma, Zhuang; Zheng, Youguang; Wu, Dawei; Tang, Zhongzhi; Zhang, Minzhou; Pan, Shuming; Chai, Yanfen; Song, Yan; Zhang, Jian; Pan, Lei; Liu, Yi; Yu, He; Yu, Xuezhong; Zhang, Hong; Wang, Xiaoge; Du, Zhaohui; Wan, Xianyao; Tang, Yijun; Tian, Yingping; Zhu, Yimin; Wang, Hongliang; Yan, Xiaoyan; Liu, Zhi; Zhang, Boli; Zhong, Nanshan; Shang, Hongcai; Bai, Chunxue

doi:10.1097/ccm.0000000000003842

Public

XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial

Shared by NobleBlocks on Sep 1, 2019 • 12:00 AM UTC

Authors:

Yuanlin Song

Chen Yao

Yongming Yao

Abstract

Objectives: To investigate whether XueBiJing injection improves clinical outcomes in critically ill patients with severe community-acquired pneumonia. Design: Prospective, randomized, controlled study. Setting: Thirty-three hospitals in China. Patients: A total of 710 adults 18–75 years old with sev...

Discussions